Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CD229
CD229
CAR-T tackles multiple myeloma by using the target CD229 to kill cancer stem cells
Fierce Biotech
Mon, 02/10/20 - 10:11 am
CAR-T
Multiple Myeloma
CD229
JNJ
Bluebird Bio